Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation.
about
Synchronous recruitment of epigenetic modifiers to endotoxin synergistically activated Tnf-α gene in acute kidney injuryBrd4 activates P-TEFb for RNA polymerase II CTD phosphorylationInhibition of BET bromodomains as a therapeutic strategy for cancer drug discoveryTwo faces of brd4: mitotic bookmark and transcriptional lynchpinAn Epigenetic Compound Library Screen Identifies BET Inhibitors That Promote HSV-1 and -2 Replication by Bridging P-TEFb to Viral Gene Promoters through BRD4RNA Polymerase II C-Terminal Domain: Tethering Transcription to Transcript and TemplateOn the computational ability of the RNA polymerase II carboxy terminal domain.RNA polymerase II transcription elongation and Pol II CTD Ser2 phosphorylation: A tail of two kinases.BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin.Cyclin Dependent Kinase 9 Inhibitors for Cancer TherapyKinetically Defined Mechanisms and Positions of Action of Two New Modulators of Glucocorticoid Receptor-regulated Gene Induction.TAF7: traffic controller in transcription initiation.CIITA and Its Dual Roles in MHC Gene Transcription.Bromodomain 4: a cellular Swiss army knifeInhibitors of cyclin-dependent kinases as cancer therapeutics.Regulation of NO synthesis, local inflammation, and innate immunity to pathogens by BET family proteins.Uncovering BRD4 hyperphosphorylation associated with cellular transformation in NUT midline carcinoma.Ser7 of RNAPII-CTD facilitates heterochromatin formation by linking ncRNA to RNAi.Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex.Selective Antagonists of the Bronchiolar Epithelial NF-κB-Bromodomain-Containing Protein 4 Pathway in Viral-Induced Airway Inflammation.Discovery of BET bromodomain inhibitors and their role in target validationCross Talk between Cellular Regulatory Networks Mediated by Shared Proteins
P2860
Q27310345-DEF5516B-4BB1-470E-85DB-648FC0CCE8FDQ28240747-75F3DA02-BD8F-41A1-BE5E-852CB14EF507Q28260105-DF2DDDB0-7E07-488D-96DD-69DC2204E49CQ28278777-8FE8015C-5B6D-4004-A92D-2E72DDC97C8CQ28552849-0A4410E4-CE6E-4A8A-96C7-3AC9581DDAC5Q29540749-F445E34E-4437-4D06-AFE7-EB6271CB68BFQ30596770-EB550DEC-8C8D-407C-AB07-33A75A549046Q34046663-48EB21B9-FED2-4504-AC59-48EF28D13F8EQ34046783-0999FE68-AC05-41BF-90A4-AC8BD36CBE88Q36015334-22A81D37-9658-4BA8-B1B1-30A0814BD8E9Q36419269-1F502FDD-043E-4FD2-BA11-99F9455A9A9DQ36815365-0BB4DA4A-C13D-43AB-9F6E-4435D657E71EQ37405448-C4C6037D-13BC-40B0-93DD-87BF48337185Q38906390-0F8931D4-71B2-436B-A69B-E6890D5A46E8Q39125016-B1F13C4D-3061-4BC9-A935-6390796BF156Q41908811-F6510EAC-EB45-4D2C-9EE0-C176184D7C2DQ47119688-1E1CCD04-E478-44E6-9DB7-17E74F274AC6Q47296511-F29D76D8-52F2-4D3A-A5E2-5544195C4893Q48863076-5876EBF4-E090-4C19-808B-8B47542B0218Q52309819-5D070E6E-C538-4F3A-9E55-27789DCEE95DQ54933470-A4A3841F-70DF-4833-9DBA-FFDC72E1EE14Q59042587-C2E75CBE-C4B8-431E-86FF-6DE15436D6C4
P2860
Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation.
@ast
Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation.
@en
type
label
Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation.
@ast
Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation.
@en
prefLabel
Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation.
@ast
Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation.
@en
P2860
P356
P1476
Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation.
@en
P2093
Ballachanda N Devaiah
Dinah S Singer
P2860
P304
38755-38766
P356
10.1074/JBC.M112.412015
P407
P577
2012-10-01T00:00:00Z